Short talks Pharmacology 9
Disease models, drug development

Programme

• 08:45 – 09:00 10 Min. 5 Min.

  • Short talk
  • 38

  BBLN is up-regulated in hearts of cyanotic patients with tetralogy of Fallot and triggers cardiac dysfunction in transgenic mice

  • Andreas Langer (Zurich / CH)

   Disease models, drug development
• 09:00 – 09:15 10 Min. 5 Min.

  • Short talk
  • 39

  The sGC activator Riociguat alters pro-inflammatory activation of BV2 microglial cells

  • Elisabetta De Iaco (Marburg / DE)

   Disease models, drug development
• 09:15 – 09:30 10 Min. 5 Min.

  • Short talk
  • 40

  Dimethylglyoxal: a reactive pyruvate metabolite that mediates neurological complications of diabetes

  • Riccardo Costalunga (Lübeck / DE)

   Disease models, drug development
• 09:30 – 09:45 10 Min. 5 Min.

  • Short talk
  • 41

  Uncovering enhanced antisense oligonucleotide uptake in injured cardiomyocytes through high-resolution miRNA activity sensing

  • Petros Avramopoulos (Munich / DE)

   Disease models, drug development
• 09:45 – 10:00 10 Min. 5 Min.

  • Short talk
  • 42

  Human Multi-Tissue Organoids as an Advanced Teratogenicity Model

  • Robert Zweigerdt (Hannover / DE)

   Disease models, drug development